Havas Health Network

This is NOT just a healthcare topic. GLP-1s will undoubtedly have a long-term ripple effect on  brands across all sectors including food & beverage, retail, health insurance, travel & hospitality, fitness, and beyond. We are only just beginning to understand the full impact of GLP-1s, but a world of possibility already awaits – and with the market for these drugs expected to reach around 31.5 million US consumers by 2035, every brand will need a GLP-1 strategy. Join us tomorrow for #GLP101Day live at Havas’ downtown NYC offices for a day filled with discussions you don’t want to miss. This is your last chance to RSVP, email us at global.comms@havas.com. #Converged #MeaningfulBrands #OneHavas #GLP1 Havas

Havas Health is thrilled to announce the appointment of Anna Maria Marra as CEO of Europe!   In this position, she will oversee all European agency CEOs and report directly to Donna Murphy, CEO of Havas Health and Havas Creative Networks. After 20 years at Pfizer, Anna is ready to integrate her pharma expertise into the work we do at Havas Health.    Thank you, Jack O'Brien and MM+M for covering. Read more here: https://lnkd.in/eTkFXyuS   #OneHavas #MeaningfulDifference

This Wednesday, November 13th, Havas is hosting GLP101 Day – a curated, invite-only event dedicated to bringing together brands, medical experts, influencers and beyond to discuss the far-reaching impact of GLP-1s on every industry.   Our final panel of the day, “The Social Pulse,” moderated by Marc Iskowitz, Executive Editor, MM+M, will dive into how social media platforms have reshaped the way health conversations evolve online and how consumers engage with treatments like GLP-1 therapies. Panelists Dr. Cedric "Jamie" Rutland MD FCCP, Medical Director, and Social Influencer; Dorothy Gemmell, Chief Commercial Officer and President, GoodRx; and Kelly Millett – Health Strategy, Havas Media Network; will join the conversation to explore social influence’s impact on consumer decision-making in the GLP-1 era. To save your spot at #GLP101Day on Wednesday 11/13, please email global.comms@havas.com. #Converged #MeaningfulBrands #OneHavas #GLP1

On November 13th, Divya Dileep, recently appointed Executive Creative Director at Jacques, is partnering with Bliss Bio Health to discuss and promote diversity and the shaping of more inclusive campaigns.   Register for the event here: https://bit.ly/3BVc5SR #OneHavas #MeaningfulDifference #MAHF

Join us for “The Metabolic Mirror” at Havas’ GLP101 Day next Wednesday, November 13th. The discussion moderated by Davitha Tiller, Head of Social and Integrated Communications, Havas, will dive into how GLP-1s are holding up a new kind of mirror to society that is potentially transforming not just individual bodies, but our collective understanding of beauty itself. Hear from Chloé Depiesse, Head of Digital Strategy, Havas NOW; Erica Pagliarulo, Enterprise Global Account Director, Agency & Consumer Brands Division, Meltwater; and internationally recognized physician expert, Dr. Jennifer Pearlman MD CCFP NCMP FAARM ABAARM. To save your spot at #GLP101Day on Wednesday 11/13, please email global.comms@havas.com. #Converged #MeaningfulBrands #OneHavas #GLP1

AdForum sat down with Dirk Poschenrieder, Managing Director, Havas Consumer Health Germany to discuss the omnichannel strategies that are reshaping healthcare marketing. Learn more about Dirks POV on the challenges faced by pharmaceutical companies, and the exciting opportunities presented by advancements in digital health technologies. Read more here: https://lnkd.in/dpEyjwWz #OneHavas #MeaningfulDifference  

On Wednesday, November 13th, 2024, leaders from around the industry will gather at Havas’ NY offices to tackle this era of multi-industry disruption from GLP-1s. The second panel of the day, “Curbing your Consumption,” will explore the multifaceted impact of these medications and how they are impacting consumption across verticals ranging from food, alcohol, FMCG, and everything in between. Join us as moderator Mia Lehmkuhl Libby, SVP, The Wall Street Journal, takes the stage with Anna Whiteman, Partner, Coefficient Capital; Bill Shufelt, Co-Founder and CEO, Athletic Brewing Co.; and Kate Kenner Archibald, CMO, Dash Hudson; to discuss how GLP-1s are reshaping not just waistlines, but entire industries and cultural norms. To save your spot at #GLP101Day on Wednesday 11/13, please email global.comms@havas.com. #Converged #MeaningfulBrands #OneHavas #GLP1

We are excited to be kicking off GLP101 Day with “GLP-1s On Our Mind,” a thought-provoking discussion about how GLP-1s are impacting not just our bodies — but our minds and society at large. Moderator Sonika (Shankar) Garcia, MPH, VP, Associate Director, Medical Anthropology, Havas Health, will unpack the complex neurological and social implications of GLP-1s to explore how these drugs may be affecting our brains and our societal attitudes, with featured panelists John Lilliquist, SVP, iHeartMedia Health; Shailja Dixit, CEO, Curio Digital Therapeutics Inc.; Joseph Perekupka, CEO, Freespira; and Suketu Patel, Global Chief Medical Officer, Havas.  To save your spot at #GLP101Day on Wednesday 11/13, please email global.comms@havas.com.  #Converged #MeaningfulBrands #OneHavas #GLP1  

It's TCS New York City Marathon weekend and our New York offices are getting excited — and prepared to race! Thanks to Julia Walker and Campaign US for the lovely feature on Hannah Roesler and Carrie G. Goldberg, CHES®, two of our amazing Jacques Madison team members running the marathon this weekend. Best of luck to you both and all who are participating. We will be in the crowd cheering you on! Read the full feature here: https://lnkd.in/gzzsb2B8 #OneHavas Havas

You may be asking: what are GLP-1s and how are they relevant to my business?   GLP-1s are being described by some as the “biggest disruption of our time.” GLP-1s (think Ozempic, Wegovy and Mounjaro) are a class of drugs used to treat type 2 diabetes and obesity. But this all goes much deeper than just weight loss. These medications are impacting nearly every way consumers interact with brands – their consumption patterns, purchasing behavior, societal perceptions & attitudes, and so much more.   Join us for Havas’ #GLP101Day on Wednesday, November 13th from 12:15pm to 5:30pm to dive deeper and learn why every brand will need a GLP-1 strategy.   Email global.comms@havas.com for more info!   #Converged #MeaningfulBrands #OneHavas #GLP1